68 | Radioisotopes (Radionuclides)IBA
05/2022
-
02/2002 |
35 | ErbB Receptors (EGF Receptor)IBA
01/2022
-
08/2004 |
25 | Proteins (Proteins, Gene)FDA Link
11/2021
-
02/2004 |
25 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
10/2020
-
02/2007 |
18 | Monoclonal AntibodiesIBA
01/2022
-
11/2004 |
17 | Trastuzumab (Herceptin)FDA Link
01/2022
-
06/2005 |
16 | Bombesin Receptors (Bombesin Receptor)IBA
11/2021
-
01/2013 |
16 | Chelating AgentsIBA
03/2020
-
11/2006 |
13 | human ERBB2 proteinIBA
01/2022
-
06/2005 |
13 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
11/2021
-
05/2011 |
12 | AntigensIBA
07/2020
-
10/2005 |
11 | Epidermal Growth Factor (EGF)IBA
01/2021
-
05/2003 |
10 | Pharmaceutical PreparationsIBA
02/2022
-
10/2007 |
10 | 1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA
12/2020
-
03/2012 |
8 | Designed Ankyrin Repeat ProteinsIBA
05/2022
-
01/2018 |
8 | AntibodiesIBA
06/2020
-
08/2003 |
7 | BombesinIBA
01/2020
-
01/2013 |
7 | Pentetic Acid (DTPA)FDA LinkGeneric
12/2019
-
08/2003 |
7 | Cys-ZHER2-342 affibodyIBA
01/2018
-
02/2007 |
6 | Epithelial Cell Adhesion MoleculeIBA
05/2022
-
02/2020 |
6 | AlbuminsIBA
02/2022
-
01/2018 |
6 | Peptides (Polypeptides)IBA
10/2020
-
01/2002 |
6 | ABY-025IBA
03/2020
-
04/2010 |
6 | AndrogensIBA
07/2014
-
04/2011 |
5 | Indium-111IBA
07/2021
-
04/2007 |
5 | Tyrosine Kinase InhibitorsIBA
01/2021
-
11/2014 |
5 | LigandsIBA
06/2020
-
04/2006 |
4 | Immunoconjugates (Immunoconjugate)IBA
05/2022
-
11/2006 |
3 | seribantumabIBA
09/2021
-
01/2018 |
3 | Carbonic Anhydrase IXIBA
12/2019
-
11/2016 |
3 | Hormones (Hormone)IBA
01/2019
-
04/2011 |
3 | Cetuximab (Erbitux)FDA Link
01/2019
-
01/2011 |
3 | Biomarkers (Surrogate Marker)IBA
01/2018
-
07/2010 |
3 | Peptide Nucleic AcidsIBA
01/2018
-
01/2016 |
3 | Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2017
-
03/2009 |
3 | Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
04/2016
-
01/2007 |
3 | Cysteine (L-Cysteine)FDA Link
04/2015
-
03/2007 |
2 | Glucose (Dextrose)FDA LinkGeneric
06/2022
-
02/2016 |
2 | EpitopesIBA
11/2021
-
05/2012 |
2 | Aligeron (AS 2)IBA
01/2021
-
06/2010 |
2 | 68Ga-ABY-025IBA
03/2020
-
01/2016 |
2 | EnzymesIBA
01/2020
-
11/2016 |
2 | G250 monoclonal antibodyIBA
12/2019
-
02/2015 |
2 | CobaltIBA
11/2019
-
01/2017 |
2 | Immunoglobulin FragmentsIBA
10/2019
-
02/2016 |
2 | Immunoglobulins (Immunoglobulin)IBA
01/2018
-
01/2016 |
2 | pertuzumabIBA
01/2018
-
01/2007 |
2 | Technetium (Technetium 99m)IBA
01/2018
-
03/2006 |
2 | CD44v6 antigenIBA
02/2016
-
01/2010 |
2 | Oncogene Proteins (Oncogene Protein)IBA
10/2015
-
06/2006 |
2 | IndiumIBA
06/2014
-
11/2007 |
2 | IodineIBA
06/2014
-
03/2006 |
2 | IsotopesIBA
07/2013
-
11/2004 |
2 | RadiopharmaceuticalsIBA
03/2011
-
03/2007 |
2 | DABIIBA
01/2010
-
11/2004 |
2 | dodecaborateIBA
01/2010
-
11/2004 |
2 | benzyl-DTPAIBA
09/2007
-
08/2003 |
2 | N- (2- amino- 3- (para- isothiocyanatophenyl)propyl)cyclohexane- 1,2- diamine- N,N,N',N',N'- pentaacetic acidIBA
03/2007
-
11/2006 |
2 | Benzoates (Benzoate)IBA
07/2006
-
11/2004 |
1 | Alkaline PhosphataseIBA
05/2022 |
1 | OsteopontinIBA
05/2022 |
1 | ExotoxinsIBA
05/2022 |
1 | Gallium-66IBA
11/2021 |
1 | glycylhistidineIBA
01/2021 |
1 | Copper-64IBA
12/2020 |
1 | Cobalt-55IBA
12/2020 |
1 | Human Serum AlbuminFDA LinkGeneric
10/2020 |
1 | Blood Proteins (Serum Proteins)IBA
01/2020 |
1 | phosphoramidonIBA
12/2019 |
1 | pimonidazoleIBA
12/2019 |
1 | GlutamatesIBA
08/2019 |